Savoring every drop - Vampire or Mosquito?

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Fischer, Dania P ^a   Zacharowski, Kai D ^a   Meybohm, Patrick ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; ANTICOAGULATION; ARTERIAL GAS; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD VOLUME; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN DETERMINATION; HEMOSTASIS; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE; INTENSIVE CARE UNIT; PATIENT SAFETY; PRIORITY JOURNAL; TREATMENT OUTCOME; ADVERSE EFFECTS; BLOOD AUTOTRANSFUSION; BLOOD LOSS, SURGICAL; CROSS INFECTION; INFECTION CONTROL; PROCEDURES; RISK FACTOR; STANDARDS;

ANEMIA; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CROSS INFECTION; HEMOSTASIS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PATIENT SAFETY; RISK FACTORS;

EID: 84901362959     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13884     Document Type: Article

References (41)

1. Tang YD, Katz SD. The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes. Heart Fail Rev 2008, 13:387-392. 10.1007/s10741-008-9089-7, 18246424.
2. Tang YD, Katz SD. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006, 113:2454-2461. 10.1161/CIRCULATIONAHA.105.583666, 16717164.
3. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ. The CRIT Study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med 2004, 32:39-52. 10.1097/01.CCM.0000104112.34142.79, 14707558.
4. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011, 378:1396-1407. 10.1016/S0140-6736(11)61381-0, 21982521.
5. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D, . ABC (Anemia and Blood Transfusion in Critical Care) Investigators Anemia and blood transfusion in critically ill patients. JAMA 2002, 288:1499-1507. 10.1001/jama.288.12.1499, 12243637, ABC (Anemia and Blood Transfusion in Critical Care) Investigators.
6. Thomas J, Jensen L, Nahirniak S, Gibney RT. Anemia and blood transfusion practices in the critically ill: a prospective cohort review. Heart Lung 2010, 39:217-225. 10.1016/j.hrtlng.2009.07.002, 20457342.
7. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, . German Red Cross NAT Study Group Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion 2008, 48:1558-1566. 10.1111/j.1537-2995.2008.01718.x, 18466173, German Red Cross NAT Study Group.
8. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008, 36:2667-2674. 10.1097/CCM.0b013e3181844677, 18679112.
9. Shander A, Goodnough LT. Why an alternative to blood transfusion?. Crit Care Clin 2009, 25:261-277. 10.1016/j.ccc.2008.12.012, 19341908.
10. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009, 113:3406-3417. 10.1182/blood-2008-10-167643, 19188662.
11. Rohde JM, Dimcheff DE, Blumberg N, Saint S, Langa KM, Kuhn L, Hickner A, Rogers MA. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014, 311:1317-1326. 10.1001/jama.2014.2726, 24691607.
12. Silver MJ, Li YH, Gragg LA, Jubran F, Stoller JK. Reduction of blood loss from diagnostic sampling in critically ill patients using a blood-conserving arterial line system. Chest 1993, 104:1711-1715. 10.1378/chest.104.6.1711, 8252948.
13. Nguyen BV, Bota DP, Melot C, Vincent JL. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003, 31:406-410. 10.1097/01.CCM.0000048623.00778.3F, 12576944.
14. Burnum JF. Medical vampires. N Engl J Med 1986, 314:1250-1251. 10.1056/NEJM198605083141910, 3702922.
15. Wang TJ, Mort EA, Nordberg P, Chang Y, Cadigan ME, Mylott L, Ananian LV, Thompson BT, Fessler M, Warren W, Wheeler A, Jordan M, Fifer MA. A utilization management intervention to reduce unnecessary testing in the coronary care unit. Arch Intern Med 2002, 162:1885-1890. 10.1001/archinte.162.16.1885, 12196088.
16. O'Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, Masur H, . American College of Critical Care Medicine; Infectious Diseases Society of America Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Crit Care Med and the Infectious Diseases Society of America. Crit Care Med 2008, 36:1330-1349. 10.1097/CCM.0b013e318169eda9, 18379262, American College of Critical Care Medicine; Infectious Diseases Society of America.
17. Dupuy AM, Philippart F, Péan Y, Lasocki S, Charles PE, Chalumeau M, Claessens YE, Quenot JP, Guen CG, Ruiz S, Luyt CE, Roche N, Stahl JP, Bedos JP, Pugin J, Gauzit R, Misset B, Brun-Buisson C, . Maurice Rapin Institute Biomarkers Group Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections. Ann Intensive Care 2013, 3:22. 10.1186/2110-5820-3-22, 3708786, 23837559, Maurice Rapin Institute Biomarkers Group.
18. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812. 10.1172/JCI200318921, 161431, 12813013.
19. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK. Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 2005, 115:1299-1306. 10.1542/peds.2004-1680, 2867083, 15867038.
20. Oto J, Nakataki E, Hata M, Tsunano Y, Okuda N, Imanaka H, Nishimura M. Comparison of bacterial contamination of blood conservation system and stopcock system arterial sampling lines used in critically ill patients. Am J Infect Control 2012, 40:530-534. 10.1016/j.ajic.2011.08.006, 22054688.
21. Smoller BR, Kruskall MS, Horowitz GL. Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 1989, 91:701-703.
22. Low LL, Harrington GR, Stoltzfus DP. The effect of arterial lines on blood-drawing practices and costs in intensive care units. Chest 1995, 108:216-219. 10.1378/chest.108.1.216, 7606961.
23. Frasca D, Dahyot-Fizelier C, Catherine K, Levrat Q, Debaene B, Mimoz O. Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients. Crit Care Med 2011, 39:2277-2282. 10.1097/CCM.0b013e3182227e2d, 21666449.
24. O'Reilly M. Understanding noninvasive and continuous hemoglobin monitoring. Crit Care Med 2013, 41:e52. 10.1097/CCM.0b013e318283c379, 23591235.
25. Coquin J, Dewitte A, Manach YL, Caujolle M, Joannes-Boyau O, Fleureau C, Janvier G, Ouattara A. Precision of noninvasive hemoglobin-level measurement by pulse co-oximetry in patients admitted to intensive care units for severe gastrointestinal bleeds. Crit Care Med 2012, 40:2576-2582. 10.1097/CCM.0b013e318258fb4f, 22732278.
26. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005, 20:155-161. 10.1016/j.jcrc.2005.01.001, 16139156.
27. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004, 30:260-265. 10.1007/s00134-003-2047-x, 14600809.
28. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012, 59:810-818. 10.1053/j.ajkd.2011.11.030, 22226564.
29. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care 2006, 10:222. 10.1186/cc4975, 1750988, 16879728.
30. Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012, 117:531-547. 10.1097/ALN.0b013e318264c644, 22914710.
31. Tanaka KA, Bader SO, Gorlinger K. Novel approaches in management of perioperative coagulopathy. Curr Opin Anaesthesiol 2014, 27:72-80. 10.1097/ACO.0000000000000025, 24263685.
32. Dietrich W, Faraoni D, von Heymann C, Bolliger D, Ranucci M, Sander M, Rosseel P. ESA guidelines on the management of severe perioperative bleeding: comments on behalf of the Subcommittee on Transfusion and Haemostasis of the European Association of Cardiothoracic Anaesthesiologists. Eur J Anaesthesiol 2014, 31:239-241. 10.1097/EJA.0000000000000033, 24296821.
33. Lelubre C, Vincent JL. Red blood cell transfusion in the critically ill patient. Ann Intensive Care 2011, 1:43. 10.1186/2110-5820-1-43, 3207872, 21970512.
34. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005, 33:1191-1198. 10.1097/01.CCM.0000165566.82925.14, 15942330.
35. Gombotz H, Zacharowski K, Spahn DR. Patient Blood Management: Individuelles Behandlungskonzept zur Reduktion und Vermeidung von Anämie 2013, Stuttgart: Thieme Verlag Stuttgart, 1, [Patient Blood Management: Individualized concept to reduce and avoid anemia].
36. Walsh TS, McClelland DB, Lee RJ, Garrioch M, Maciver CR, McArdle F, Crofts SL, Mellor I, Group AS. Prevalence of ischaemic heart disease at admission to intensive care and its influence on red cell transfusion thresholds: multicentre Scottish Study. Br J Anaesth 2005, 94:445-452. 10.1093/bja/aei073, 15708870.
37. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4. CD002042.
38. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417. 10.1056/NEJM199902113400601, 9971864.
39. Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, Forbes JF, Ramsay P, Pearse R, Wallis C, Cairns C, Cole S, Wyncoll D, . RELIEVE Investigators Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013, 41:2354-2363. 10.1097/CCM.0b013e318291cce4, 23939351, RELIEVE Investigators.
40. Hofmann A, Ozawa S, Farrugia A, Farmer SL, Shander A. Economic considerations on transfusion medicine and patient blood management. Best Pract Res Clin Anaesthesiol 2013, 27:59-68. 10.1016/j.bpa.2013.02.001, 23590916.
41. Loor G, Rajeswaran J, Li L, Sabik JF, Blackstone EH, McCrae KR, Koch CG. The least of 3 evils: exposure to red blood cell transfusion, anemia, or both?. J Thorac Cardiovasc Surg 2013, 146:1480-1487. e1486, 10.1016/j.jtcvs.2013.06.033, 23998782.